Members of the fatty acid binding protein family are differentiation factors for the mammary gland. 1994

Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
Max Delbrück Center for Molecular Medicine, Berlin, Germany.

Mammary gland development is controlled by systemic hormones and by growth factors that might complement or mediate hormonal action. Peptides that locally signal growth cessation and stimulate differentiation of the developing epithelium have not been described. Here, we report that recombinant and wild-type forms of mammary-derived growth inhibitor (MDGI) and heart-fatty acid binding protein (FABP), which belong to the FABP family, specifically inhibit growth of normal mouse mammary epithelial cells (MEC), while growth of stromal cells is not suppressed. In mammary gland organ culture, inhibition of ductal growth is associated with the appearance of bulbous alveolar end buds and formation of fully developed lobuloalveolar structures. In parallel, MDGI stimulates its own expression and promotes milk protein synthesis. Selective inhibition of endogenous MDGI expression in MEC by antisense phosphorothioate oligonucleotides suppresses appearance of alveolar end buds and lowers the beta-casein level in organ cultures. Furthermore, MDGI suppresses the mitogenic effects of epidermal growth factor, and epidermal growth factor antagonizes the activities of MDGI. Finally, the regulatory properties of MDGI can be fully mimicked by an 11-amino acid sequence, represented in the COOH terminus of MDGI and a subfamily of structurally related FABPs. This peptide does not bind fatty acids. To our knowledge, this is the first report about a growth inhibitor promoting mammary gland differentiation.

UI MeSH Term Description Entries
D008321 Mammary Glands, Animal MAMMARY GLANDS in the non-human MAMMALS. Mammae,Udder,Animal Mammary Glands,Animal Mammary Gland,Mammary Gland, Animal,Udders
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009924 Organ Culture Techniques A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1) Organ Culture,Culture Technique, Organ,Culture Techniques, Organ,Organ Culture Technique,Organ Cultures
D010452 Peptide Biosynthesis The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation (TRANSLATION, GENETIC). There are other, non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules. Biosynthesis, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier

Related Publications

Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
November 2003, The Journal of biological chemistry,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
October 1998, FEBS letters,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
January 1986, Comparative biochemistry and physiology. B, Comparative biochemistry,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
June 1995, European journal of biochemistry,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
February 1993, Biochemical and biophysical research communications,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
October 1985, Biochemical Society transactions,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
January 1975, Methods in enzymology,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
October 2010, The Journal of biological chemistry,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
January 2024, Cell death discovery,
Y Yang, and E Spitzer, and N Kenney, and W Zschiesche, and M Li, and A Kromminga, and T Müller, and F Spener, and A Lezius, and J H Veerkamp
June 2009, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!